Ieva Ruža FEFIM’s Post

🎉 Important announcement! 🎉 We've extended the Early Bird registration deadline! Don't miss your chance to save with the Early Bird fee. Register now and secure your spot at a discounted rate! New Deadline: 31 July 2024 🔗https://lnkd.in/eSi2Mm3d #EarlyBird #EventRegistration #DontMissOut #SaveTheDate

I am extremely happy to share with you the launching of our special article collection in Therapeutics and Clinical Risk Management journal from Taylor & Francis Group, entitled "Older and newer players in the therapeutics of Cardio-Kidney-Metabolic syndrome"! Our special article collection is now open for submissions, while the deadline for submission is 31 December 2024!

We have open positions at JMIR Publications! Check them all out here: https://lnkd.in/e9GGk66V We have an amazing and fast-growing team of Scientific Editors, and YOU could be the next one to join us! Check out the full job posting about the Scientific Editor position, including key responsibilities and qualifications, at JMIR Publications and apply to join our team today! *Description #ScientificEditor Do you thrive on intellectual exchange and leading-edge research? JMIR Publications offers the chance to join a forward-thinking team, shaping the discourse on the latest breakthroughs. As a full-time Scientific Editor, you will leverage your expertise in #digitalhealth #research / #medicalinformatics (or adjacent fields) to assess cutting-edge research, collaborate with a world-class network of experts, and contribute to shaping the future of #healthcare. Adjacent fields may also include #publichealth, #HealthServicesResearch, machine learning and #artificialintelligence applications. Join us and make a real impact in #OpenScience! Primary Duties and Responsibilities Reporting to the Scientific Editorial Director and working closely with the Founding Publisher and the editorial team, the Scientific Editor will help shape and carry out scientific activities supporting high-quality #publication, #ResearchIntegrity, and author experience. Education: PhD, or MD or MD/PhD in the field of medical informatics or digital health, or adjacent fields such as public health, health services research; MSc or Masters in these fields may also be considered when there is applicable experience (see job post: https://lnkd.in/e23Kh6Kq). #OpenAccess #Publishing #Editor #Medicine #eHealth #mHealth #Healthcare #Wellbeing

🥳 European Hormone Day is here! ESE, the ESE Foundation and the endocrine community across Europe are joining forces today to raise awareness of the vital role of hormones in preventing + treating disease. Hormones play a major role in many prevalent chronic diseases (such as cancer, diabetes and thyroid disease), and over 400 rare diseases. These affect millions of people in Europe.  While we need policymakers to lay the groundwork for better prevention, diagnosis and treatment, there are steps we can all take to improve our hormone health. That’s our focus today. Help spread the word by sharing and following #BecauseHormonesMatter  Find out more: www.europeanhormoneday.org    #EuropeanHormoneDay 

Yesterday I had the pleasure to moderate the seventh iteration of the WHO Decoding #Data and #DigitalHealth webinar series. We focused on the #reimbursement and #valuation of digital health technologies. The adoption of digital health within #healthsystems is complex. Robust reimbursement mechanisms are quintessential, facilitating access to new digital health technologies. A recent study from the The London School of Economics and Political Science (LSE) and WHO Regional Office for Europe concluded that countries show divergent approaches to digital health reimbursement. #Valuebased reimbursing digital health technologies is largely non-existent. We looked to disentangle some of these prominent issues to arrive at action points for advancing digital health reimbursement. Some key takeaways from the webinar: 1️⃣ We are at the precipice of a paradigm shift. Digital health does not adhere to the rules of pharmacological interventions and should therefore not be measured with those same metrics. A need for dedicated valuation tools and willingness-to-pay thresholds for digital health technologies was made abundantly clear. 2️⃣ The value of digital health goes beyond clinical outcomes. There is a dire need to understand what dimensions and metrics beyond strictly clinical outcomes can be proactively and positively influenced by digital health technologies, pointing towards the social determinants of health. 3️⃣ Harmonisation efforts for health technology assessments are in progress, but at the same time direly needed. A common standard for health technology assessments for digital health technologies can eliminate a large degree of uncertainty in terms of what evidence standards need to be met in order to access the European healthcare market. 4️⃣ With over 300,000 health apps being freely available on various app stores, it becomes impossible for citizens, patients, health professionals, or decision-makers to distinguish the good from the bad without clear quality labels. A standardised quality label for health apps is on the horizon, after which the endeavour to start testing and appraising both novel and existing health apps can commence. I would like to thank the panelists Petra Hoogendoorn, Fruzsina Mezei, Louisa Stüwe, Steven Vandeput, PhD., and Kyle Longton, CAE, REBC for their vibrant discussion and insights. I would also like to thank Ryan Dos Santos and Dr Stefan Buttigieg MD MSPH MSc for their support leading up to and during the webinar. 📖 Read more about current digital health reimbursement strategies in Europe: https://lnkd.in/eYmFYjby 📖 Read more about what it takes to implement digital therapeutics in health systems: https://lnkd.in/e_-fmKgz 📖 Read more on the state of digital health in the European region: https://lnkd.in/e9tsFN7G

Today is World Sarcoidosis Day! Let's unite in solidarity to raise awareness, support those affected, and advocate for better research and treatments. Together, we can make a difference. https://lnkd.in/gJvJbvs5 #SarcoidosisAwarenessDay #April13 #SaySarcoidosis #StopSarcoidosis #PostinPurple #WorldSarcDay #WorldSarcoidosisDay #SarcDay

Today I have the pleasure of sharing my recent interview with publishing house "Rigas Viņi" where I discuss the journey and future aspirations of leading Riga's Eastern Clinical University Hospital towards new horizons of healthcare excellence. In this conversation, I delve into our collective achievements, the transformative power of digital innovation in healthcare, and our unwavering commitment to enhancing patient care. It's a reflection of our journey, highlighting the challenges we've faced and the milestones we've achieved in striving for a healthcare system that's not only efficient but also compassionate and accessible to all. As we navigate the complexities of modern healthcare, it's clear that innovation, teamwork, and a patient-centered approach are the keystones to delivering superior care. I'm incredibly proud of our team's resilience and dedication to setting new standards in healthcare. I invite you to read the full interview (it is in Latvian) and join me in this ongoing conversation about the future of healthcare, the role of technology in improving patient outcomes, and how we can all contribute to a healthier tomorrow. Your support and feedback mean the world to us as we continue to innovate and improve. Let's keep pushing the boundaries of what's possible in healthcare together. https://lnkd.in/dJmBzh2U #HealthcareInnovation #DigitalTransformation #PatientCare #TeamworkMakesTheDreamWork #RigaEasternClinicalUniversityHospital